SCHEMBL4834201

SCHEMBL4834201

ClCC(Cl)Cl.O=C(O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28068869 0.83
Tetrachloroethylene SCHEMBL9734827 0.77 TSHR (0.42)
Methylene Chloride SCHEMBL28160039 0.76
Methylene Chloride SCHEMBL7847615 0.76 TSHR (0.54)
Chloroform SCHEMBL27824229 0.76
SCHEMBL16435 0.76
SCHEMBL28154792 0.76 TSHR (0.40)
Methacrylic Acid SCHEMBL11232963 0.74 TDP1 (0.36)
Acetamide SCHEMBL28866674 0.73
Methyl Alcohol SCHEMBL1871619 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7320989-B2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-22 US disclosed
US-20080004312-A1 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists ENCYSIVE PHARMACEUTICALS, INC. 2008-01-03 US disclosed
US-20050054850-A1 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists ENCYSIVE PHARMACEUTICALS INC. 2005-03-10 US disclosed